Key Takeaways
- • Shah Capital has ended its campaign to influence Novavax after restructuring into a family office, Himanshu Shah Family Office LLC.
- • The firm withdrew its registration as an investment adviser as part of the restructuring.
- • Shah Capital first pushed for leadership change at Novavax in 2024, after building a 6.7% stake and opposing director re-election.
Summary
Shah Capital has ended its activist campaign at Novavax following a restructuring of the firm into a family office, Himanshu Shah Family Office LLC. As part of the change, the firm withdrew its registration as an investment adviser.
The campaign began in 2024, when Shah Capital built a 6.7% stake in the vaccine developer and pushed for a change in leadership. The fund also opposed the re-election of certain directors. The publisher summary does not provide further detail on the outcome of those efforts or on the terms of the exit.
The campaign began in 2024, when Shah Capital built a 6.7% stake in the vaccine developer and pushed for a change in leadership. The fund also opposed the re-election of certain directors. The publisher summary does not provide further detail on the outcome of those efforts or on the terms of the exit.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.